Clinical Trial Update: Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection [NA]

View source ↗

Summary

Clinical trial comparing 5-ALA photodynamic therapy to CO2 laser for persistent low-grade cervical lesions in high-risk HPV patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• 5-aminolevulinic acid (5-ALA) photodynamic therapy (5-aminolevulinic acid)
• CO2 laser

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions | NA | Status: RECRUITING